BlackRock’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$161M Buy
17,998,329
+1,668,226
+10% +$13.3M ﹤0.01% 1797
2025
Q4
$98.5M Buy
16,330,103
+362,447
+2% +$2.16M ﹤0.01% 2120
2025
Q3
$91.2M Sell
15,967,656
-185,534
-1% -$949K ﹤0.01% 2157
2025
Q2
$81.4M Sell
16,153,190
-388,140
-2% -$2.08M ﹤0.01% 2182
2025
Q1
$107M Buy
16,541,330
+78,613
+0.5% +$699K ﹤0.01% 1944
2024
Q4
$121M Buy
16,462,717
+86,911
+0.5% +$686K ﹤0.01% 1967
2024
Q3
$123M Sell
16,375,806
-58,316
-0.4% -$507K ﹤0.01% 1967
2024
Q2
$146M Sell
16,434,122
-129,490
-0.8% -$1.24M ﹤0.01% 1800
2024
Q1
$168M Sell
16,563,612
-300,967
-2% -$3.07M ﹤0.01% 1761
2023
Q4
$170M Buy
16,864,579
+1,060,666
+7% +$9.69M ﹤0.01% 1751
2023
Q3
$148M Buy
15,803,913
+1,828,956
+13% +$26.1M ﹤0.01% 1746
2023
Q2
$343M Buy
13,974,957
+19,466
+0.1% +$489K 0.01% 1195
2023
Q1
$325M Sell
13,955,491
-181,137
-1% -$4.63M 0.01% 1211
2022
Q4
$358M Buy
14,136,628
+262,902
+2% +$6.44M 0.01% 1113
2022
Q3
$267M Buy
13,873,726
+1,062,036
+8% +$27M 0.01% 1259
2022
Q2
$326M Buy
12,811,690
+7,415,506
+137% +$173M 0.01% 1160
2022
Q1
$139M Buy
5,396,184
+88,135
+2% +$2.61M ﹤0.01% 1919
2021
Q4
$222M Buy
5,308,049
+148,420
+3% +$5.81M 0.01% 1655
2021
Q3
$225M Buy
5,159,629
+177,991
+4% +$7.71M 0.01% 1627
2021
Q2
$236M Sell
4,981,638
-303,802
-6% -$13.8M 0.01% 1643
2021
Q1
$271M Sell
5,285,440
-163,037
-3% -$8.79M 0.01% 1500
2020
Q4
$146M Buy
5,448,477
+1,374,316
+34% +$44.7M ﹤0.01% 1838
2020
Q3
$140M Buy
4,074,161
+212,472
+6% +$9.15M 0.01% 1675
2020
Q2
$158M Buy
3,861,689
+3,417,871
+770% +$115M 0.01% 1519
2020
Q1
$15.2M Buy
443,818
+166,769
+60% +$4.48M ﹤0.01% 2750
2019
Q4
$3.48M Buy
+277,049
New +$3.71M ﹤0.01% 3610

Other funds holding VIR